1. Home
  2. PRSO vs HIND Comparison

PRSO vs HIND Comparison

Compare PRSO & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.69

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

HOLD

Current Price

$2.00

Market Cap

15.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
HIND
Founded
2008
2017
Country
United States
United States
Employees
N/A
18
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
15.2M
IPO Year
2000
2016

Fundamental Metrics

Financial Performance
Metric
PRSO
HIND
Price
$0.69
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$15.00
AVG Volume (30 Days)
321.7K
11.8K
Earning Date
05-11-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
81.23
N/A
EPS
N/A
N/A
Revenue
$14,573,000.00
N/A
Revenue This Year
$18.48
N/A
Revenue Next Year
$53.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.99
N/A
52 Week Low
$0.68
$1.75
52 Week High
$2.37
$12.87

Technical Indicators

Market Signals
Indicator
PRSO
HIND
Relative Strength Index (RSI) 33.54 39.79
Support Level N/A $1.99
Resistance Level $0.94 $2.33
Average True Range (ATR) 0.05 0.08
MACD -0.00 -0.02
Stochastic Oscillator 12.21 0.00

Price Performance

Historical Comparison
PRSO
HIND

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: